In this study, a commercially available human serum sample was used, with the addition of interfering biomarkers such as interleukin‐1β (IL‐1β), TNF‐α, and C‐reactive protein (CRP)—all relevant to IBD—to simulate the serum composition of IBD patients.155. Here, CRP is linked to inflammatory bowel disease.